BMO Capital Markets downgraded Chemours from Outperform to Underperform and set a new price target of $19.00 from $45.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $19.00 | Neutral → Outperform | Mizuho |
| 1/28/2025 | $27.00 | Buy | Truist |
| 7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
| 6/7/2024 | $25.00 | Neutral | Mizuho |
| 4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
| 3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
| 2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
| 12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00
Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virginia. Chemours is expected to pay EPA and WVDEP a $22.5 million civil penalty over a three-year period, and fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and enhance certain existing off-site drinking water programs.The settlement recognizes that Chemours has already begun planning and implementing operational improvements and remedial measures at its facilities, and contains further actions the Company will take to mitigate future emi
WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2026 financial results after market on Tuesday, May 5, 2026.The Company expects to hold its conference call to discuss its first quarter 2026 financial results at 8:00 a.m. Eastern Time on Wednesday, May 6, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com.Conference Call: Please visit investors.chemours.
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE:CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the "Notes") that was exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Notes are Chemours' senior unsecured obligations and are guaranteed by one of its subsidiaries.Chemours used the net proceeds from the offering, together with cash on hand, to fund the redemption of $188,000,000 aggregate principal amount of its 5.750% senior notes due 2028 for an aggregate redemption price of app
The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virginia. Chemours is expected to pay EPA and WVDEP a $22.5 million civil penalty over a three-year period, and fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and enhance certain existing off-site drinking water programs.The settlement recognizes that Chemours has already begun planning and implementing operational improvements and remedial measures at its facilities, and contains further actions the Company will take to mitigate future emi
WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2026 financial results after market on Tuesday, May 5, 2026.The Company expects to hold its conference call to discuss its first quarter 2026 financial results at 8:00 a.m. Eastern Time on Wednesday, May 6, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com.Conference Call: Please visit investors.chemours.
WILMINGTON, Del., Feb. 17, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE:CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the first quarter of 2026. The dividend will be paid on March 13, 2026, to stockholders of record as of the close of business on February 27, 2026.About The Chemours CompanyThe Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through ou
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
8-K - Chemours Co (0001627223) (Filer)
SD - Chemours Co (0001627223) (Filer)
S-8 - Chemours Co (0001627223) (Filer)
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C
Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke